Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
Ottawa, ON (July 10, 2019) — Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new Patient and Community Advisory Committee.
Twelve individuals from across the country have been invited to join the committee as inaugural members. Committee members are…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
See Pharmaceutical Reviews Update – Issue 8 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:
details around when patient groups may be re-engaged in the CADTH Common Drug Review (CDR) process following an initial call for patient input…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
CADTH has received the following notice(s) of pending drug submission(s).
Benlysta
Brand name
Benlysta
Generic name
belimumab
Manufacturer
GlaxoSmithKline Inc.
Indication(s)
Systemic lupus erythematosus
Project Number
SR0616-000
Call for patient input
2019-04-30
Patient input deadline
2019-06-19…
See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised…
CADTH is pleased to announce the appointment of Dr. Nicole Mittmann, MSc., PhD, as CADTH Chief Scientist and Vice-President of Evidence Standards.
Dr. Mittmann will lead CADTH’s shared science groups, including our Health Economics, Research Information Services, and Scientific Affairs teams. She…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
See Pharmaceutical Reviews Update — Issue 6 for important news and information regarding CADTH’s drug review programs. Highlights from this issue:
The latest news about CADTH’s new Patient and Community Advisory Committee.
Updates to the fee guidance for applications to CADTH’s Pharmaceutical…
Ottawa, ON (March 28, 2019) — CADTH is pleased to celebrate outstanding and ongoing achievements in the field of health technology assessment (HTA) by announcing the recipients of the 2019 CADTH Recognition Awards.
In addition to honouring two individuals who have made significant contributions to…
A document related to the project entitled Non-Pharmacological Prevention of Pressure Injuries: An Environmental Scan is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Consultation Document
Product Type
Submit Stakeholder Feedback
Non-…